News und Analysen

• Are These 3 Under-the-Radar AI Stocks the Next Big Growth Stories?

Audioeye (NASDAQ:AEYE) reported first-quarter 2026 revenue growth and raised its profitability outlook, while outlining a

• Bargain Alert on 3 Stocks Investors Have Oversold

Amentum (NYSE:AMTM) reported what executives described as solid second-quarter fiscal 2026 results, supported by growth in key markets, strong

Veritone (NASDAQ:VERI) reported lower first-quarter revenue but reaffirmed its full-year 2026 outlook, citing growing demand for its AI training data services, public sector software and recently

Novanta (NASDAQ:NOVT) reported stronger-than-expected first-quarter 2026 results, with management citing broad-based bookings growth, accelerating demand in automation and medical markets, and

Figure Technology Solutions (NASDAQ:FIGR) reported sharply higher first-quarter 2026 revenue and profitability as executives emphasized that the company is positioning itself as a blockchain-native

• How Did Peter Thiel-Backed Crypto Exchange Bullish's IPO Go?

eToro Group (NASDAQ:ETOR) reported a strong start to 2026, with executives pointing to record public-company net contribution and

Ubiquiti’s (NYSE: UI) business is strong and drives value for its investors. However, some factors suggest its stock price will remain under pressure for the foreseeable future. The primary is

• Russell 2000 Stocks: Too Early or Finally Interesting?

Mueller Water Products (NYSE:MWA) reported record fiscal second-quarter results and raised its full-year adjusted EBITDA outlook, citing

• Savvy Investors' Rate Cut Portfolio: Bonds, Small Caps, Energy

Murphy Oil (NYSE:MUR) reported first-quarter 2026 results that management said reflected stronger-than-expected production, higher oil

• Matador’s Results Were Better Than Feared, But 2026 Headwinds Still Matter

Mettler-Toledo International (NYSE:MTD) reported first-quarter 2026 sales growth and higher adjusted earnings, with

Cannae (NYSE:CNNE) said it returned the bulk of its first-quarter capital allocation to shareholders while continuing to evaluate sales of non-core holdings and emphasizing growth in its

aTyr Pharma (NASDAQ:ATYR) said it plans to conduct a new Phase III trial of efzofitimod in pulmonary sarcoidosis after receiving feedback from the U.S. Food and Drug Administration at a recent Type

Kaltura (NASDAQ:KLTR) reported first-quarter 2026 results that exceeded its guidance for revenue and adjusted EBITDA, while also generating positive operating cash flow in a first quarter for the

• DocGo: A Growth Stock Going Higher In 2023

DocGo (NASDAQ:DCGO) reported first-quarter revenue of $75.6 million and an adjusted EBITDA loss of $10.2 million, as executives pointed to accelerating

• Insider Sales: Top AST SpaceMobile Insider Cuts Postion Over 30%

AST SpaceMobile (NASDAQ:ASTS) said it remains on track with its 2026 deployment and revenue plans as the satellite-to-smartphone

• Hidden Gems: 3 Value Stocks to Watch for Strong 2025 Returns

Conduent (NASDAQ:CNDT) reported improved profitability and cash flow in the first quarter of 2026 while outlining a broader plan to

• This Small Cap Wealth Management Stock Could Provide Big Returns

AlTi Global (NASDAQ:ALTI) reported higher first-quarter 2026 revenue and adjusted EBITDA, as management said recurring advisory fees

Telos (NASDAQ:TLS) reported a stronger-than-expected first quarter for fiscal 2026, with revenue and adjusted EBITDA exceeding the company’s guidance as growth in TSA PreCheck enrollment activity

Priority Technology (NASDAQ:PRTH) reported higher first-quarter revenue and profit as growth in its Payables and Treasury Solutions businesses continued to outpace its Merchant Solutions segment